MAPT and Insulin resistance: Taken together, insulin resistance may not directly cause AD; however, insulin resistance can increase the risk of developing AD by exacerbating AD pathology (e.g., Aβ, tau and chronic neuroinflammation) and, in turn, promote further insulin resistance—a feed‐forward loop (Wei et al., 2021).